Literature DB >> 30273697

Olfactory function and cognition in relapsing-remitting and secondary-progressive multiple sclerosis.

A Carotenuto1, T Costabile2, M Moccia3, F Falco2, M R Scala2, C V Russo2, F Saccà2, A De Rosa2, R Lanzillo2, V Brescia Morra2.   

Abstract

BACKGROUND: Both cognition and olfaction are impaired in multiple sclerosis (MS). However, little is known about the relationship between smell identification ability and measures of cognitive function in this disease.
OBJECTIVE: To assess olfactory function in MS and to evaluate its relationship with cognitive and physical disability.
METHODS: Fifty-five MS patients and 20 healthy controls (HCs) were tested. The University of Pennsylvania smell identification test (UPSIT) was administered to assess olfactory function. Cognitive function was tested using the symbol digit modalities test (SDMT), California verbal learning test-II (CVLT II), brief visuospatial memory test (BVMT), paced auditory serial addition test (PASAT), and controlled oral word association test (COWAT). Fatigue and depressive symptoms were evaluated using the Modified Fatigue Impact Scale and the Beck Depression Inventory II, respectively.
RESULTS: MS patients had lower UPSIT scores than those of the HCs (28.76 ± 5.48 vs 31.7 ± 2.18, p = 0.02), with secondary-progressive and cognitively impaired MS patients showing the greatest impairment. Scores on the SDMT, CVLTII, BVMT and COWAT were related to the olfactory test scores.
CONCLUSION: We confirm that olfactory function is impaired in MS, particularly in progressive phenotypes, and show, for the first time, that such dysfunction is related to a broad range of cognitive measures. Our data suggest that olfactory dysfunction might be considered as an indirect measure of MS severity. Longitudinal studies are needed to confirm this possibility.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomarkers; Cognition; Multiple sclerosis; Neurodegeneration; Olfactory function; Progressive

Mesh:

Year:  2018        PMID: 30273697     DOI: 10.1016/j.msard.2018.09.024

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  7 in total

1.  Olfaction and Executive Cognitive Performance: A Systematic Review.

Authors:  Vasudeva Murthy Challakere Ramaswamy; Peter William Schofield
Journal:  Front Psychol       Date:  2022-05-09

2.  Anosmia in COVID-19: Mechanisms and Significance.

Authors:  Albert Y Han; Laith Mukdad; Jennifer L Long; Ivan A Lopez
Journal:  Chem Senses       Date:  2020-06-17       Impact factor: 3.160

3.  Mapping the Microstructure and Striae of the Human Olfactory Tract with Diffusion MRI.

Authors:  Shiloh L Echevarria-Cooper; Guangyu Zhou; Christina Zelano; Franco Pestilli; Todd B Parrish; Thorsten Kahnt
Journal:  J Neurosci       Date:  2021-11-10       Impact factor: 6.167

4.  Olfactory dysfunction in patients with multiple sclerosis; A systematic review and meta-analysis.

Authors:  Omid Mirmosayyeb; Narges Ebrahimi; Mahdi Barzegar; Alireza Afshari-Safavi; Sara Bagherieh; Vahid Shaygannejad
Journal:  PLoS One       Date:  2022-04-19       Impact factor: 3.240

5.  Olfactory dysfunction is common in classical infratentorial superficial siderosis of the central nervous system.

Authors:  Natallia Kharytaniuk; E A Lim; E Chan; M Pavlou; D J Werring; D E Bamiou
Journal:  J Neurol       Date:  2022-08-23       Impact factor: 6.682

Review 6.  Particles Containing Cells as a Strategy to Promote Remyelination in Patients With Multiple Sclerosis.

Authors:  Jorge Matías-Guiu; Jordi A Matías-Guiu; Paloma Montero-Escribano; Juan A Barcia; Alejandro A Canales-Aguirre; Juan C Mateos-Diaz; Ulises Gómez-Pinedo
Journal:  Front Neurol       Date:  2020-07-07       Impact factor: 4.003

7.  Remifentanil reduces glutamate toxicity in rat olfactory bulb neurons in culture.

Authors:  Muhammet Emin Naldan; Ali Taghizadehghalehjoughi
Journal:  Braz J Anesthesiol       Date:  2021-04-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.